Thanks guys, I tried to google the old posts but didnt come up with any. I did reread the phase 1 trails and Regabatin looks promising....it will be larger than Rexista and the company even outlines that in their presentations. Its the current sleeper because everyone is focused on the lead drug Rexista. I really see a partnership coming in 2017 for this one.